Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference68 articles.
1. Tinsley SM, Grande C, Olson K, Plato L, Jacobs I. Potential of biosimilars to increase access to biologics: considerations for advanced practice providers in oncology. J Adv Pract Oncol. 2018;9(7):699–716. https://doi.org/10.6004/jadpro.2018.9.7.2.
2. Karateev D, Belokoneva N. Evaluation of physicians’ knowledge and attitudes towards biosimilars in Russia and issues associated with their prescribing. Biomolecules. 2019;9:1–16. https://doi.org/10.3390/biom9020057.
3. Ilham M, Hafidz A, Jayaraman T, Affendi R, Ali R, Lee YY. Are we ready for biosimilars in gastroenterology? EMJ Gastroenterol. 2017;6(1):83–9.
4. World Health Organization. Report on the expert consultation on improving access to and use of similar biotherapeutic products. 2017;1–25. https://www.who.int/medicines/access/biotherapeutics/FINAL_Report-improving-access-to-and-use-of-biotherapeutics_October2017.pdf. Accessed 20 Aug 2021.
5. Isaacs JD, Cutolo M, Keystone EC, Park W, Braun J. Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibody. J Intern Med. 2016;279:41–59. https://doi.org/10.1111/joim.12432.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献